GF
Gates Foundation Portfolio holdings
AUM
$43.5M
This Quarter Return
+35.09%
1 Year Return
+14.19%
3 Year Return
-58.08%
5 Year Return
–
10 Year Return
–
AUM
$611M
AUM Growth
+$611M
(+40%)
Cap. Flow
+$41.6M
Cap. Flow
% of AUM
6.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Immunocore
IMCR
|
$24.6M |
| 2 |
Butterfly Network
BFLY
|
$17M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.09% |
| 2 | Materials | 0.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CureVac
CVAC
$1.21B
| $287M | 46.92% | 3,134,780 | – | – |
|
2
Vir Biotechnology
VIR
$686M
| $142M | 23.3% | 2,777,777 | – | – |
|
3
BioNTech
BNTX
$24B
| $113M | 18.56% | 1,038,674 | – | – |
|
|
4
Immunocore
IMCR
$1.62B
| $24.6M | 4.02% | +576,923 | New | +$24.6M |
|
|
BCEL
5
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $21.4M | 3.5% | 1,396,644 | – | – |
|
|
6
Butterfly Network
BFLY
$405M
| $17M | 2.78% | +1,011,003 | New | +$17M |
|
|
AMRS
7
DELISTED
Amyris Inc.
AMRS
| $5.59M | 0.91% | 292,398 | – | – |
|